is leading the charge for advanced gynecology innovation around the world – for every woman, everywhere.
Our Story
read more
Currently, 45% of pregnancies and one-third of births in the U.S. are unplanned or associated with feelings of ambivalence. Women make up 51% of the population. Yet 100% of the time, they are the ones on the frontline of the consequences.
Historically funding, research, and programs that prioritize women’s issues are scarce. And politics can change the paradigm of her choices at any time.
Introducing Intimo Medical – the home for proactive women’s healthcare. Here, Scarlett’s story and the countless others like it, have turned into our calling. We’ve set out to become the premiere company in the world for innovative healthcare solutions that put women in control.
To start, we developed a groundbreaking, 3-D, non-hormonal, anatomically shaped contraceptive device, that is tiny-but-mighty and fits the needs of the dynamic 21st-century woman.
We call it Scarlett.
But we won’t stop there. At Intimo, we have many more plans – for user-friendly fertility devices, sensor-based gynecology instruments to make treatments gentler, and much more. We are working hard to change gynecology today, so it will be as efficient, woman-centered, and liberating as possible.
Safety.
Comfort.
Protection.
T-shape IUDs
Worldwide, almost half of all pregnancies are unintended and often this is caused by some disconnect in contraceptive use. For example, common contraceptives like pills or condoms need to be used consistently for optimal efficiency, and sometimes there is a lapse. And T-shaped copper intrauterine devices are highly effective, but they have significant side effects that make women uncomfortable and can lead them to remove their IUDs early.
~50% of all pregnancies worldwide are unintended – that’s 120 million each year!
>$5.5 billion is spent annually in the US alone, to deal with the consequences of low contraceptive adherence
IUD expulsion rates of up to 10% expose women to unprotected situations
IUD embedment rates of up to 18% may raise a potential risk for T-frame breakage
Perforation rates of 1/1000 cases may raise a potential risk of surgical intervention
Early IUD discontinuation rates are up to 40% within the first two years of use
The Groundbreaking IU3D Intrauterine Platform
When it comes to intrauterine devices, development has stagnated. The traditional T-shaped IUD has not changed in more than 30 years! Meanwhile, there has always been room for improvement with it because, of course, the uterus is not a simple T; rather it is a three-dimensional organ shaped like a pear. This mismatch between a T-shaped device and a full-bodied organ, among other factors, is at the heart of many traditional IUD complications and failures.
Scarlett’s Novelty
Top-Level Safe and Adaptable
- Scarlett offers the first IUD self-expanding technology that forms itself to even the narrowest uterine cavity.
read more
- Its anatomical fit – a rounded and closed pear-like shape – will improve safety, and significantly reduce the risk of embedment or perforation.
- Made of super-elastic material, it modifies itself to the natural contractions of the uterus.
Benefits for Women
- Non-traumatic – The thinnest possible Inserter with a rounded tip is designed to enable insertion of the small, grape-sized device, without discomfort.
read more
- Reliable – Radial expansion allows for self-retaining in the uterine cavity. This significantly reduces the risk of spontaneous expulsion that would leave a woman without protection.
- Hormone-Free – Contraception without the use of hormones – and based on copper, which has been used effectively and safely in the world for over 30 years.
Benefits for HCPs
- Intuitive and user-friendly – A pre-loaded, ready-to-use, one-handed applicator ensures a quick learning curve for healthcare providers.
read more
- Maneuverable – The most flexible and low-profile Inserter possible is designed to enable maneuvering for both the anteverted and retroverted uterus.
- Comfortable – The unique structure of the device folds into a narrow profile when pulled out, allowing for easy and safe removal.
Pipeline and Market Potential
Intimo is first in the market to present a proprietary versatile intrauterine delivery device of solid or liquid substances for multiple clinical indications and therapies. Our technology allows this through an intimate and discreet IU3D in the uterine cavity without requiring connection to external devices. Its potential is vast.
1
Infertility
Slow-release artificial insemination (SRI)
- Worldwide, 17% of people suffer from infertility, illustrating the need for affordable, high-quality fertility treatment.
read more
- Artificial Insemination has a global market share of $2B.
- Most insemination catheters on the market release semen using the bolus technique known as IUI, and its efficacy is relatively low.
- IU3D could be used as a discreet carrier for semen release, which is gradually introduced into the uterus over time to mimic the natural process and improve efficacy.
1
Contraception
Hormonal IUD
- Hormonal IUD as a contraceptive has a global market share of $2B.
read more
- The common types on the market are highly effective but their significant side effects have been reported for over two decades.
- IU3D could serve as a safe and reliable hormonal IUD while reducing the side effects associated with the traditional T-shaped device.
1
Bleeding
AUB / HMB
- Abnormal Uterine Bleeding and Heavy Menstrual Bleeding have a global market share of >$3B for hormonal IUDs and ablation therapies.
read more
- They affect one in three women throughout their reproductive years and impact their quality of life.
- Their heavy economic burden on the system in the US is estimated at $1B direct cost and $12B indirect cost.
- Treatment with IU3D could take place in the office for the local release of hormones or active substances into the uterus and for reduced bleeding.
